Fexofenadine Hydrochloride
NDC 68016-995, Fexofenadine hydrochloride, tablet, from Chain Drug Consortium, LLC.
- Product NDC
- 68016-995
- Status
- Listed
- Labeler
- Chain Drug Consortium, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA076502
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68016-995 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEXOFENADINE HYDROCHLORIDE180 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68016-995-03 | 68016099503 | 1 BOTTLE in 1 CARTON (68016-995-03) / 30 TABLET in 1 BOTTLE |
| 68016-995-45 | 68016099545 | 1 BOTTLE in 1 CARTON (68016-995-45) / 45 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 68016-995 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68016-995 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68016-995. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.